EUVIMEDEUVIMED entdecken
Crossref

Continuous-Flow Four-Step Synthesis of a Key Synthetic Intermediate for Tivozanib and Cabozantinib

Mark Lautens, Andrew G. Durant

Synfacts · 01.09.2026 · 22 (09) · 877

DOI: 10.1055/a-2915-0287 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Synfacts, erschienen am 01.09.2026. Verfasst von Mark Lautens und 1 weiteren Autor:innen. Die Arbeit nennt 1 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Lautens, M., & Durant, A. G. (2026). Continuous-Flow Four-Step Synthesis of a Key Synthetic Intermediate for Tivozanib and Cabozantinib. Synfacts, 22(09), 877. https://doi.org/10.1055/a-2915-0287

Vancouver

Lautens M, Durant AG. Continuous-Flow Four-Step Synthesis of a Key Synthetic Intermediate for Tivozanib and Cabozantinib. Synfacts. 2026;22(09):877. doi:10.1055/a-2915-0287

BibTeX
@article{Lautens2026,
  author = {Lautens, Mark and Durant, Andrew G.},
  title = {Continuous-Flow Four-Step Synthesis of a Key Synthetic Intermediate for Tivozanib and Cabozantinib},
  journal = {Synfacts},
  year = {2026},
  volume = {22},
  number = {09},
  pages = {877},
  doi = {10.1055/a-2915-0287}
}
Kostenlos starten →